[go: up one dir, main page]

ES2097426T3 - Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos. - Google Patents

Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.

Info

Publication number
ES2097426T3
ES2097426T3 ES93118993T ES93118993T ES2097426T3 ES 2097426 T3 ES2097426 T3 ES 2097426T3 ES 93118993 T ES93118993 T ES 93118993T ES 93118993 T ES93118993 T ES 93118993T ES 2097426 T3 ES2097426 T3 ES 2097426T3
Authority
ES
Spain
Prior art keywords
procedure
cystine bridges
proinsulin
correctly
united
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118993T
Other languages
English (en)
Inventor
Rainer Dr Obermeier
Martin Dr Gerl
Jurgen Ludwig
Walter Sabel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2097426T3 publication Critical patent/ES2097426T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA OBTENCION DE PROINSULINA CON PUENTES DE CISTINA COMBINADOS CORRECTAMENTE A PARTIR DE UNA ADECUADA CADENA DE ACIDO PROINSULINAAMINO EN PRESENCIA DE MERCAPTANO, SUSTANCIAS AUXILIARES CAOTROPAS Y UN VALOR PH DESDE 10 HASTA 11. ASI COMO SU AISLAMIENTO DIRECTO A PARTIR DE LA FORMULA DE REACCION CON AYUDA DE RESINA ADSORBENTE HIDROFOBA.
ES93118993T 1992-12-02 1993-11-25 Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos. Expired - Lifetime ES2097426T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4240420 1992-12-02

Publications (1)

Publication Number Publication Date
ES2097426T3 true ES2097426T3 (es) 1997-04-01

Family

ID=6474135

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118993T Expired - Lifetime ES2097426T3 (es) 1992-12-02 1993-11-25 Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.

Country Status (13)

Country Link
US (1) US5473049A (es)
EP (1) EP0600372B1 (es)
JP (1) JP2798351B2 (es)
AT (1) ATE148710T1 (es)
AU (1) AU662083B2 (es)
CA (1) CA2110442C (es)
DE (1) DE59305396D1 (es)
DK (1) DK0600372T3 (es)
ES (1) ES2097426T3 (es)
FI (1) FI108727B (es)
HK (1) HK1006170A1 (es)
NO (1) NO308216B1 (es)
SG (1) SG46612A1 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
CA2213301C (en) * 1995-02-20 2010-01-26 Amrad Operations Pty. Ltd. Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
SE9504019D0 (sv) * 1995-11-13 1995-11-13 Pharmacia Ab Method for production of proteins
DE59711533D1 (de) 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
KR100253916B1 (ko) * 1997-12-29 2000-05-01 김충환 사람 인슐린 전구체의 제조방법
CN1197876C (zh) 1998-03-31 2005-04-20 通化安泰克生物工程有限公司 含有分子内伴侣样序列的嵌合蛋白及其在胰岛素生产中的应用
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
WO2000040613A1 (en) 1999-01-06 2000-07-13 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
EP1141015B1 (en) * 1999-01-06 2009-07-15 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants
JP3406244B2 (ja) * 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
AU2151401A (en) 1999-12-22 2001-07-03 Novo Nordisk A/S Method for extractive refolding of scrambled single-chain polypeptides
US20020164712A1 (en) * 2000-12-11 2002-11-07 Tonghua Gantech Biotechnology Ltd. Chimeric protein containing an intramolecular chaperone-like sequence
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
DE10235168A1 (de) * 2002-08-01 2004-02-12 Aventis Pharma Deutschland Gmbh Verfahren zur Reinigung von Preproinsulin
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
CN101605889A (zh) * 2008-02-12 2009-12-16 伊藤火腿株式会社 含有高表达分泌胰岛素前体的融合蛋白、编码该融合蛋白的dna和胰岛素的制备方法
JP5677938B2 (ja) * 2008-04-30 2015-02-25 ウォックハート リサーチ センター インシュリンの再折りたたみ方法
US9526764B2 (en) 2008-10-17 2016-12-27 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a GLP-1-agonist
HUE038147T2 (hu) 2009-11-13 2018-09-28 Sanofi Aventis Deutschland GLP-1 agonistát, inzulint és metionint tartalmazó gyógyászati készítmény
WO2011058082A1 (de) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten und methionin
WO2012028172A1 (en) 2010-08-30 2012-03-08 Sanofi-Aventis Deutschland Gmbh Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es) 2011-08-29 2014-04-09 Sanofi Aventis Deutschland Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
EP2931301B2 (en) 2012-12-17 2021-09-15 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
US10407483B2 (en) 2014-03-14 2019-09-10 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
HRP20230470T1 (hr) 2014-12-12 2023-07-21 Sanofi-Aventis Deutschland Gmbh Formulacija fiksnog omjera inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2017040363A1 (en) 2015-09-02 2017-03-09 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196609A (en) 1980-03-27 1984-02-03 Lilly Co Eli Preparation of proinsulin-like insulin precursors
US4430266A (en) * 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
NZ199391A (en) 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DE3501641A1 (de) * 1985-01-19 1986-07-24 Hoechst Ag, 6230 Frankfurt Verfahren zur gewinnung von insulin-vorlaeufern aus reaktionsgemischen, die bei der faltung von insulin-vorlaeufern aus den entsprechenden s-sulfonaten anfallen
DE3537708A1 (de) 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
DE4012818A1 (de) 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3726655A1 (de) * 1987-08-11 1989-02-23 Hoechst Ag Verfahren zur isolierung basischer proteine aus proteingemischen, welche solche basischen proteine enthalten
DE58906966D1 (de) 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
GB8819826D0 (en) * 1988-08-20 1988-09-21 Kabivitrum Ab Glycosylated igf-1
DE3901719A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur herstellung eines insulinvorlaeufers
US5227293A (en) * 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.

Also Published As

Publication number Publication date
FI108727B (fi) 2002-03-15
CA2110442A1 (en) 1994-06-03
NO934357L (no) 1994-06-03
SG46612A1 (en) 1998-02-20
DK0600372T3 (da) 1997-08-11
NO308216B1 (no) 2000-08-14
NO934357D0 (no) 1993-11-30
EP0600372A1 (de) 1994-06-08
JPH06228191A (ja) 1994-08-16
AU662083B2 (en) 1995-08-17
HK1006170A1 (en) 1999-02-12
EP0600372B1 (de) 1997-02-05
CA2110442C (en) 2004-05-04
JP2798351B2 (ja) 1998-09-17
AU5203993A (en) 1994-06-16
US5473049A (en) 1995-12-05
ATE148710T1 (de) 1997-02-15
DE59305396D1 (de) 1997-03-20
FI935358L (fi) 1994-06-03
FI935358A0 (fi) 1993-11-30

Similar Documents

Publication Publication Date Title
ES2097426T3 (es) Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
ES2119241T3 (es) Procedimiento para la obtencion de insulina con puentes de cistina unidos correctamente.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
ATE378075T1 (de) Biologisch resorbierbare kalzium phosphate zement-zusammensetzungen
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
AU5779400A (en) Process for the preparation of 3,3-dimethylbutanal
SE8204627D0 (sv) Process for preparing insulin derivatives
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
ATE50595T1 (de) 2-oxocarbonsaeurereduktase, ihre herstellung und verwendung.
GB2170800B (en) 2-aminobenzamides
ZA848194B (en) Perfumery compounds and their preparations
ES2157232T3 (es) Procedimiento para la preparacion de 2,4,5-tribromo-pirrol-3-carbonitrilo.
DE59501436D1 (de) Verfahren zur Herstellung von 2-Cyaniminothiazolidin
NO995132D0 (no) Fremgangsmåte for reduksjon av fibrinogen
JPS5290694A (en) Preparation of protoporphyrine 1x
MX9205611A (es) Procedimiento para la preparacion de: 1-amino-4-metilpiperazina
FI961674A0 (fi) Foerfarande foer beklaedning av madrass och beklaedningsanordning foer madrass
MY124079A (en) Process for producing 1, 2-dimethyl-3-hydroxypyrid-4- one
AU8241091A (en) The use of formamidine sulfinic acid as an oxygen scavenger
MD950100A (en) Substituted oximethers method of their preparation and application for pests and fungus control
MX9207565A (es) Hidroxilacion.
JO1590B1 (en) Use of calcium sulfate to improve fermentation of organic waste
MX9205607A (es) Procedimiento para la preparacion de: griseofulvina

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 600372

Country of ref document: ES